In contrast, MMR germline carriers with ovarian cancer showed higher somatic variant rates in oncogenic driver genes, suggesting a heterogeneous etiology of tumorigenesis mediated by MMR germline variants in endometrial cancer. This evidence concerns the gene MRC1 and ovarian cancer.